View Author
treatment patient delay symptom symptom onset infarction onset group presentation delay presentation effect hospital therapy mortality heart hospital arrival arrival treatment delay study trial benefit death gusto-i thrombolysi table state stroke 0.1 outcome characteristic gusto factor relation function jacc vol treatment effect thrombolytic shock occlusion analysis 5.7 distribution failure initiation newby family infarct result difference myocardii infarction interval variable delay times baseline 0.7 education programs history vessel occlusion strategy treatment delays family history interaction change estimate patient characteristics heart failure 3.4 3.7 mm hg survival streptokinase report enrollment site treatment drh ~ya ti lumily history srrokr \& types therapy 1 h study cd show time-dependent treatment ekcts stroke abet thrombolysis
3 Most Recent Publications
|
Selection of thrombolytic therapy for individual patients: development of a clinical model
(Article)
Califf, R.M. Woodlief, L.H. Topol, E.J. Harrell, F.E. Lee, K.L. White, H.D. Guerci, A.D. Barbash, G.I. Simes, R.J. Weaver, W.D. Simoons, M.L. |
1997-01-01
|
|
Time From Symptom Onset to Treatment and Outcomes after Thrombolytic Therapy
(Article)
Newby, L.K. Rutsch, W.R. Califf, R.M. Simoons, M.L. Aylward, P.E. Armstrong, P.W. Woodlief, L.H. Lee, K.L. Topol, E.J. Werf, F.J.J. van de |
1996-06-01
|
|
Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction
(Article)
Lee, K.L. Woodlief, L.H. Topol, E.J. Weaver, W.G. Betriu, A. Col, J.J. Simoons, M.L. Aylward, P.E. Califf, R.M. Werf, F.J.J. van de |
1995-01-01
|